• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Immunol . C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire

tetano

Editor, Senior Moderator
Sci Immunol


. 2024 Mar 22;9(93):eadj9534.
doi: 10.1126/sciimmunol.adj9534. Epub 2024 Mar 22. C1q enables influenza hemagglutinin stem binding antibodies to block viral attachment and broadens the antibody escape repertoire

Ivan Kosik[SUP] 1 [/SUP], Jefferson Da Silva Santos[SUP] 1 [/SUP], Mathew Angel[SUP] 1 [/SUP], Zhe Hu[SUP] 1 [/SUP], Jaroslav Holly[SUP] 1 [/SUP], James S Gibbs[SUP] 1 [/SUP], Tanner Gill[SUP] 1 [/SUP], Martina Kosikova[SUP] 2 [/SUP], Tiansheng Li[SUP] 1 [/SUP], William Bakhache[SUP] 3 [/SUP], Patrick T Dolan[SUP] 3 [/SUP], Hang Xie[SUP] 2 [/SUP], Sarah F Andrews[SUP] 4 [/SUP], Rebecca A Gillespie[SUP] 5 [/SUP], Masaru Kanekiyo[SUP] 5 [/SUP], Adrian B McDermott[SUP] 4 [/SUP], Theodore C Pierson[SUP] 6 [/SUP], Jonathan W Yewdell[SUP] 1 [/SUP]



Affiliations
Abstract

Antigenic drift, the gradual accumulation of amino acid substitutions in the influenza virus hemagglutinin (HA) receptor protein, enables viral immune evasion. Antibodies (Abs) specific for the drift-resistant HA stem region are a promising universal influenza vaccine target. Although anti-stem Abs are not believed to block viral attachment, here we show that complement component 1q (C1q), a 460-kilodalton protein with six Ab Fc-binding domains, confers attachment inhibition to anti-stem Abs and enhances their fusion and neuraminidase inhibition. As a result, virus neutralization activity in vitro is boosted up to 30-fold, and in vivo protection from influenza PR8 infection in mice is enhanced. These effects reflect increased steric hindrance and not increased Ab avidity. C1q greatly expands the anti-stem Ab viral escape repertoire to include residues throughout the HA, some of which cause antigenic alterations in the globular region or modulate HA receptor avidity. We also show that C1q enhances the neutralization activity of non-receptor binding domain anti-SARS-CoV-2 spike Abs, an effect dependent on spike density on the virion surface. These findings demonstrate that C1q can greatly expand Ab function and thereby contribute to viral evolution and immune escape.


 
Back
Top Bottom